| Literature DB >> 35463022 |
Shengzhe Ma1, Yue Yu1, Anfu Pan1, Haifeng Gong1, Zheng Lou1, Lianjie Liu1, Liqiang Hao1, Ronggui Meng1, Jinke Sui1, Wei Zhang1.
Abstract
Purpose: To explore the treatments and short-term effects of different types of adult Hirschsprung's disease.Entities:
Keywords: Hirschsprung’s disease (HD); megacolon; pathogenisis; retrospective study; surgical methods
Year: 2022 PMID: 35463022 PMCID: PMC9024099 DOI: 10.3389/fmed.2022.870342
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Patient characteristics.
| Characteristics | Quantity (%) |
|
| |
| Mean ± SD | 43.61 ± 15.782 |
| Range | 16–73 |
|
| |
| Female | 40 |
| Male | 49 |
|
| |
| Congenital megacolon | 41 (46.1%) |
| Adult idiopathic megacolon | 35 (39.3%) |
| Ganglion cell deficiency | 2 (2.25%) |
| Toxic megacolon | 3 (3.38%) |
| Iatrogenic megacolon | 8 (7.87%) |
|
| |
| With | 89 (100%) |
| Without | 0 (0%) |
|
| |
| None | 75 (84.3%) |
| Diabetes | 2 (2.2%) |
| Hypertension | 11 (12.4%) |
| Hypertension + diabetes | 1 (1.1%) |
|
| |
| None | 84 (94.4%) |
| Tumor | 1 (1.1%) |
| Diverticula | 4 (4.5%) |
|
| |
| Without | 89 (100%) |
| With | 0 (0%) |
|
| |
| Abdominal distension | 69 (77.5%) |
| Abdominal pain | 16 (18.0%) |
| Diarrhea | 4 (4.5%) |
|
| |
| Class I | 30 (33.7%) |
| Class II | 50 (56.2%) |
| Class III | 9 (10.1%) |
|
| 14 (15.7%) |
FIGURE 1(A) CT image of adult congenital megacolon; (B) resected specimen of adult congenital megacolon (red arrow: the stump of the rectum).
FIGURE 2(A) X-ray image manifestations of adult idiopathic megacolon; (B) CT image of adult idiopathic megacolon; (C) photos after colostomy; (D) 1 week after colostomy; (E) 1 month after colostomy; (F) the intestine specimen after subtotal resection (Red arrow: transverse colostomy).
FIGURE 3(A) Intraoperative photo of ganglion cell deficiency; (B) specimen of ganglion cell deficiency.
FIGURE 4(A,B) CT image of iatrogenic megacolon caused by colonic anastomotic stenosis; (C,D) CT images of iatrogenic megacolon after radiotherapy for rectal cancer.
Surgical method and complications.
| Efficacy and complications | Quantity (%) |
|
| |
| Diversion | 11 (12.4%) |
| Reconstruction | 78 (87.6%) |
|
| 31 (34.8%) |
|
| |
| I | 0 (0%) |
| II | 89 (100%) |
| III | 0 (0%) |
|
| 19.5 (15,26) |
|
| |
| None | 79 (83.9%) |
| Hypoproteinemia | 3 (4.8%) |
| Anemia | 2 (3.2%) |
| Abdominal effusion | 1 (1.6%) |
| Recurrent obstruction | 3 (4.8%) |
| Incision infection | 1 (1.6%) |
Differences among treatment methods.
| Diversion (11 cases) | Reconstruction (78 cases) |
| |
|
| 54.4 ± 10.6 | 42.2 ± 15.9 | 0.053 |
|
| |||
| Male | 6/11 | 43/78 | |
| Female | 5/11 | 35/78 | 0.897 |
|
| 17 (13, 26) | 20 (15, 26) | 0.834 |
|
| 3/11 | 11/78 | 0.342 |
|
| 2/11 | 3/78 | 0.026 |
|
| 3/11 | 7/78 | 0.031 |
|
| |||
| Class I | 4/11 | 26/78 | |
| Class II | 4/11 | 46/78 | |
| Class III | 3/11 | 6/78 | |
|
| 5/11 | 26/78 | 0.229 |
|
| 2/11 | 5/78 | 0.125 |
|
| 2/11 | 10/78 | 0.073 |
|
| 150 (100, 800) | 200 (200, 400) | 0.071 |
|
| 25 (3, 45) | 15 (9, 35) | 0.024 |